Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 866 entries
View as:

Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02462525 Org: User:
Start: 05/06/15 End: 12/06/17 Due: 12/06/18

A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT04138199 Org: User:
Start: 11/01/19 End: 07/08/20 Due: 07/08/21

A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03181126 Org: User:
Start: 11/27/17 End: 11/14/20 Due: 11/14/21

A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)

Phase: N/A Priority: Normal
NCT ID: NCT03695237 Org: User:
Start: 10/24/18 End: 11/29/23 Due: 11/29/24

Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01506609 Org: User:
Start: 01/23/12 End: 09/02/20 Due: 09/02/21

A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00481091 Org: User:
Start: 07/25/07 End: 05/12/22 Due: 05/12/23

Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01858519 Org: User:
Start: 08/31/13 End: 09/30/16 Due: 09/30/17

A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT02130362 Org: User:
Start: 08/28/14 End: 03/02/28 Due: 03/02/29

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06158841 Org: User:
Start: 05/19/24 End: 12/31/27 Due: 12/31/28

A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administration With On-Body Injector in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06937619 Org: User:
Start: 04/21/25 End: 11/30/25 Due: 11/30/26

Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study

Phase: N/A Priority: Normal
NCT ID: NCT02433340 Org: User:
Start: 04/30/15 End: 05/31/16 Due: 05/31/17

Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT03593213 Org: User:
Start: 07/30/18 End: 02/11/21 Due: 02/11/22

Expanded Access to Fosigotifator

Phase: N/A Priority: Normal
NCT ID: NCT06594016 Org: User:
Start: - End: - Due: -

Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of Illness

Phase: N/A Priority: Normal
NCT ID: NCT02896920 Org: User:
Start: 09/20/16 End: 04/29/19 Due: 04/29/20

An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan

Phase: N/A Priority: Normal
NCT ID: NCT05791526 Org: User:
Start: 12/19/22 End: 11/30/25 Due: 11/30/26

A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03797261 Org: User:
Start: 03/18/19 End: 12/30/19 Due: 12/30/20

Duodopa Home Titration Using Telemedicine: Evaluation of Use of Resources

Phase: N/A Priority: Normal
NCT ID: NCT01956032 Org: User:
Start: 09/30/13 End: 11/30/14 Due: 11/30/15

Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05094050 Org: User:
Start: 01/18/22 End: 03/17/23 Due: 03/17/24

A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02032277 Org: User:
Start: 04/02/14 End: 11/12/20 Due: 11/12/21

Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain

Phase: N/A Priority: Normal
NCT ID: NCT04630990 Org: User:
Start: 12/14/20 End: 03/26/24 Due: 03/26/25

A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection

Phase: N/A Priority: Normal
NCT ID: NCT02640157 Org: User:
Start: 12/31/15 End: 02/28/17 Due: 02/28/18

A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs Alone

Phase: N/A Priority: Normal
NCT ID: NCT04965272 Org: User:
Start: 08/18/21 End: 08/24/21 Due: 08/24/22

A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece

Phase: N/A Priority: Normal
NCT ID: NCT04159779 Org: User:
Start: 01/13/20 End: 06/30/26 Due: 06/30/27

A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02966756 Org: User:
Start: 10/12/17 End: 05/31/29 Due: 05/31/30

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT02203773 Org: User:
Start: 10/06/14 End: 06/16/22 Due: 06/16/23